CRISPR/Cas9 facilitates genomic editing for large-scale functional studies in pluripotent stem cell cultures
Pluripotent stem cell (PSC) cultures form an integral part of biomedical and medical research due to their capacity to rapidly proliferate and differentiate into hundreds of highly specialized cell types. This makes them a highly useful tool in exploring human physiology and disease. Genomic editing of PSC cultures is an essential method of attaining answers to basic physiological functions, developing in vitro models of human disease, and exploring potential therapeutic strategies and the identification of drug targets. Achieving reliable and efficient genomic editing is an important aspect of using large-scale PSC cultures. The CRISPR/Cas9 genomic editing tool has facilitated highly efficient gene knockout, gene correction, or gene modifications through the design and use of single-guide RNAs which are delivered to the target DNA via Cas9. CRISPR/Cas9 modification of PSCs has furthered the understanding of basic physiology and has been utilized to develop in vitro disease models, to test therapeutic strategies, and to facilitate regenerative or tissue repair approaches. In this review, we discuss the benefits of the CRISPR/Cas9 system in large-scale PSC cultures.
This work was supported by the Zhejiang Provincial Science and Technology Projects (no. LGF19H060005 to Q. N. Y.).
All authors have participated equally in drafting and revising this paper.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- Huang N, Huang Z, Gao M et al (2018) Induction of apoptosis in imatinib sensitive and resistant chronic myeloid leukemia cells by efficient disruption of bcr-abl oncogene with zinc finger nucleases. J Exp Clin Cancer Res 37:62. https://doi.org/10.1186/s13046-018-0732-4 CrossRefPubMedPubMedCentralGoogle Scholar
- Kim Y-G, Chandrasegaran S (1994) Chimeric restriction endonuclease (Flavobacterium okeanokoites/Escherichia cofi/hybrid restriction endonuclease/protein engineering/recognition and cleavage domains). Biochemistry 91:883–887Google Scholar
- Li L, Wv LP, Chandrasegaran S (1992) Functional domains in Fok I restriction endonuclease. Biochemistry 89:4275–4279Google Scholar
- Makarova KS, Grishin NV, Shabalina SA et al (2006) A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol Direct 1:7. https://doi.org/10.1186/1745-6150-1-7 CrossRefPubMedPubMedCentralGoogle Scholar
- Nakano C, Kitabatake Y, Takeyari S et al (2019) Genetic correction of induced pluripotent stem cells mediated by transcription activator-like effector nucleases targeting ALPL recovers enzyme activity and calcification in vitro. Mol Genet Metab 127:158–165. https://doi.org/10.1016/j.ymgme.2019.05.014 CrossRefPubMedGoogle Scholar
- Ran F, Hsu P, Wright J et al (2013) Genome engineering using crispr-cas9 system. Nature protocols. Nature Publishing Group, London, pp 2281–2308Google Scholar
- Sun S, Xiao J, Huo J et al (2018) Targeting ectodysplasin promotor by CRISPR/dCas9-effector effectively induces the reprogramming of human bone marrow-derived mesenchymal stem cells into sweat gland-like cells. Stem Cell Res Ther 9:1–10. https://doi.org/10.1186/s13287-017-0758-0 CrossRefGoogle Scholar